Advertising


News

In Practice: ‘All in’ for National Reconciliation Week


Morgan Liotta


21/05/2026 3:39:22 PM

Ahead of National Reconciliation Week, the RACGP is promoting events to support members to contribute to achieving reconciliation.

National Reconciliation Week
National Reconciliation Week runs from 27 May to 3 June, under the theme ‘All In’: a call to commit to reconciliation every day.

This week’s In Practice includes events and resources to support National Reconciliation Week, running from 27 May to 3 June, as well as a reminder for upcoming webinars on pharmacy prescribing consultation and vaccination for special risk groups.
 
Healing in Action: National Reconciliation Week
Webinar: Monday 2 June, 7.00–8.00 pm (AEST)
Register online

Presented by Uncle David Wragge and Stacey Wells from The Healing Foundation, alongside RACGP Aboriginal and Torres Strait Islander Health Chair Dr Karen Nicholls, this National Reconciliation Week webinar explores the ongoing health impacts of forced removal on Stolen Generations survivors and the importance of culturally safe, survivor-centred healthcare.
 
It will provide practical strategies for recognising trauma triggers, strengthening respectful communication and supporting healing for survivors.
 
Aboriginal and Torres Strait Islander health workforce webinar series
In partnership with the RACGP, the National Association for Aboriginal and Torres Strait Islander Health Workers and Practitioners (NAATSIHWP) is hosting a three-part webinar series this May–June to help GPs and practice teams integrate Aboriginal and Torres Strait Islander Health Workers and Practitioners.
 
Learn practical, culturally safe approaches and earn CPD points. Register for the webinars online. The webinar series will be officially launched at the Practice Owners Conference.
 
Aboriginal and Torres Strait Islander specific populations resource
The GPMHSC has developed a new suite of resources to assist GPs in providing inclusive, trauma-informed and culturally safe care to patients from diverse backgrounds.
 
The Aboriginal and Torres Strait Islander resource offers advice on providing trauma-informed and culturally safe care to these patients, including practical tips to build trust, ask sensitive questions respectfully, and recognise when to proceed with caution.
 
The resource also features tailored information around the unique challenges Aboriginal and Torres Strait Islander patients face, such as intergenerational trauma, systemic disadvantages to accessing care, as well as culturally relevant information such as the kinship system, sorry business, specific administrative processes, and more.
 
Pharmacy Board consultation briefing
Webinar: Tuesday 26 May, 8.30–9.30 pm (AEST)
Register online
 
The Pharmacy Board of Australia is consulting on a proposed registration-level endorsement for pharmacist prescribing. This is not only a policy change, but a structural regulatory decision with implications for how prescribing and diagnostic responsibility are managed over time.
 
The RACGP is engaging in this process with a clear focus on continuity of care, patient safety systems, and how risk is governed across the health system. Member insights are an important part of ensuring the RACGP’s submission reflects the realities of clinical care. Members are encouraged to join an upcoming webinar to better understand:

  • what is being proposed
  • the key regulatory considerations
  • how the college is representing general practice in this consultation.
The RACGP consultation page can be accessed online.
 
RACGP Awards nominations closing soon
Members are encouraged to nominate an inspiring GP, registrar, supervisor or educator for the 2026 RACGP Awards. Nominations carry real weight – they tell a colleague their commitment to their patients, community and profession has not gone unnoticed. Nominations close 9.00 am (AEST), Monday 1 June.
 
GP26 abstract submissions
This year’s RACGP flagship conference, GP26, will take place at the Adelaide Convention Centre, on Kaurna Country, from 20–22 November. The college is inviting presentation submissions across three categories: clinical learnings, research and medical education. Submissions close 11.00 pm (AEST), Tuesday 9 June.
 
For those looking for the opportunity to present at the RACGP’s biggest conference of the year, visit the GP conference website to find out more and make a submission. Early bird registrations for GP26 are now open.
 
RACGP 2026 Mentoring Program
The RACGP Mentoring Program is for seasoned GPs looking to give back to the profession and make a meaningful impact while strengthening their own leadership skills. Applications close 31 May.
 
More information is available on the RACGP website.
 
Vaccinations for special risk groups
Webinar: Tuesday 26 May, 7.00–8.00 pm (AWST)
CPD: 1 EA hour
Register online
 
Specialist GP Dr Alan Leeb will explore vaccination considerations for people at increased risk, including those with asplenia and other identified high-risk conditions. Topics will include who falls into these groups, which additional vaccines may be recommended, vaccines that may be contraindicated, and when it is appropriate to seek non-GP specialist advice. Case studies will be used to support discussion and practical application.
 
Delivered in partnership with the WA Department of Health, the webinar will be facilitated by Specialist GP and RACGP Council and Education Committee Member Dr Mariam Bahemia.
 
Australian Dementia Research Forum 2026
The annual Australian Dementia Network’s Research Forum takes place across 1–3 June in Sydney, on Gadigal Country. The program features CPD sessions for clinicians and researchers.
 
Log in below to join the conversation.
 


Aboriginal and Torres Strait Islander health culturally safe healthcare National Reconciliation Week pharmacy prescribing


newsGP weekly poll Do you have patients who will be impacted by a decision to pull low-dose goserelin (sold as Zoladex) from the Australian market in November?
 
54%
 
41%
 
4%
Related



newsGP weekly poll Do you have patients who will be impacted by a decision to pull low-dose goserelin (sold as Zoladex) from the Australian market in November?

Advertising

Advertising

 

Login to comment